The DOI matches its Crossref record.
Characterization of a leukemic cell line of the pre‐B phenotype
Abstract
NALM‐6‐M1, one of eight leukemia cell lines cultured from the blood of a 19‐year‐old boy with non‐T, non‐B acute lymphoblastic leukemia (ALL) in relapse, was characterized. This cell line was found to be more than 90% cytoplasmic Immuno‐globulin positive (clg+) for both mu heavy and lambda light chains, but surface immunoglobulln (slg) and complement receptor (CR) negative. NALM‐6‐M1 was clg∼ for alpha, delta, and gamma heavy chains and kappa light chain. About 45% of the cells exhibited sheep erythrocyte receptors. Approximately 12% of cells were positive for Fc receptors. Approximately 90% of the cultured cells had a deleted long arm of chromosome 5 (5q−) and a marker Y chromosome. The remaining 10% of cells were found to have some additional chromosomal material on the long arm of chromosome 12, suggesting a partial translocation. No other karyotypic abnormalities were found. The cell line was found to react strongly with anti‐p23, 30, suggesting la‐like activity, but it only weakly stimulated normal lymphocytes in mixed leukocyte culture (MLC). The cells expressed HLA antigens. NALM‐6‐M1 failed to react with anti‐thymocyte serum (ATS), did not possess Epstein‐Barr membrane or nuclear antigens, nor did it exhibit phagocytosis for zymosan. NALM‐6‐M1 reacted positively with oil red O and Sudan black stains. On the basis of the clgM staining, NALM‐6‐M1 seems to be arrested at an early stage in B‐cell development and is considered to be of the pre‐B cell phenotype possessing a chromosomal abnormality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)
Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., & Tada, K. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910260208 · Cited by 2,254
A one-step purification of membrane proteins using a high efficiency immunomatrix.
Schneider, C., Newman, R. A., Sutherland, D. R., Asser, U., & Greaves, M. F. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33889-4 · Cited by 764
Brueckner, B., Garcia Boy, R., Siedlecki, P., Musch, T., Kliem, H. C., Zielenkiewicz, P., Suhai, S., Wiessler, M., & Lyko, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2957 · Cited by 545
Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells.
Gougos, A., & Letarte, M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38892-1 · Cited by 452
Hermans, A., Heisterkamp, N., von Lindern, M., van Baal, S., Meijer, D., van der Plas, D., Wiedemann, L. M., Groffen, J., Bootsma, D., & Grosveld, G. (1987) · Cell · doi:10.1016/0092-8674(87)90007-9 · Cited by 387
Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine
Calonge, M. J., Gasparini, P., Chillarón, J., Chillón, M., Gallucci, M., Rousaud, F., Zelante, L., Testar, X., Dallapiccola, B., Di Silverio, F., et al. (1994) · Nature Genetics · doi:10.1038/ng0494-420 · Cited by 379
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
Ott, C. J., Kopp, N., Bird, L., Paranal, R. M., Qi, J., Bowman, T., Rodig, S. J., Kung, A. L., Bradner, J. E., & Weinstock, D. M. (2012) · Blood · doi:10.1182/blood-2012-02-413021 · Cited by 374
Widespread intraspecies cross-contamination of human tumor cell lines arising at source
MacLeod, R. A. F., Dirks, W. G., Matsuo, Y., Kaufmann, M., Milch, H., & Drexler, H. G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<555::aid-ijc19>3.0.co;2-2 · Cited by 364
Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells
Rosnet, O., Schiff, C., Pebusque, M., Marchetto, S., Tonnelle, C., Toiron, Y., Birg, F., & Birnbaum, D. (1993) · Blood · doi:10.1182/blood.v82.4.1110.1110 · Cited by 349
Hoffmann, P., Hofmeister, R., Brischwein, K., Brandl, C., Crommer, S., Bargou, R., Itin, C., Prang, N., & Baeuerle, P. A. (2005) · International Journal of Cancer · doi:10.1002/ijc.20908 · Cited by 344
Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia
Li, B., Brady, S. W., Ma, X., Shen, S., Zhang, Y., Li, Y., Szlachta, K., Dong, L., Liu, Y., Yang, F., et al. (2020) · Blood · doi:10.1182/blood.2019002220 · Cited by 288
Baldwin, J. G., Heuser-Loy, C., Saha, T., Schelker, R. C., Slavkovic-Lukic, D., Strieder, N., Hernandez-Lopez, I., Rana, N., Barden, M., Mastrogiovanni, F., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.029 · Cited by 253
False leukemia–lymphoma cell lines: an update on over 500 cell lines
Drexler, H. G., Dirks, W. G., Matsuo, Y., & MacLeod, R. A. F. (2003) · Leukemia · doi:10.1038/sj.leu.2402799 · Cited by 202
A Genome-Wide View of the In vitro Response to l-Asparaginase in Acute Lymphoblastic Leukemia
Fine, B. M., Kaspers, G. J. L., Ho, M., Loonen, A. H., & Boxer, L. M. (2005) · Cancer Research · doi:10.1158/0008-5472.291.65.1 · Cited by 103
cAMP-mediated autophagy inhibits DNA damage-induced death of leukemia cells independent of p53
Skah, S., Richartz, N., Duthil, E., Gilljam, K. M., Bindesbøll, C., Naderi, E. H., Eriksen, A. B., Ruud, E., Dirdal, M. M., Simonsen, A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25758 · Cited by 21
Metadata
- Authors
- Hurwitz, R., Hozier, J., Lebien, T., Minowada, J., Gajl‐Peczalska, K., Kubonishi, I., & Kersey, J.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1979-02-15
- Volume
- 23
- Issue
- 2
- Pages
- 174-180
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2052325839
- Cited by
- 246
- References
- 0
- FWCI
- 14.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.